Variant report
Variant | esv17034 |
---|---|
Chromosome Location | chr2:76337003-76338022 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76337965-76338015 | GM12878 | blood: | n/a |
2 | chr2:76337965-76338015 | H1-hESC | embryonic stem cell: | embryo |
3 | chr2:76337965-76338015 | NH-A | brain: | n/a |
4 | chr2:76337965-76338015 | GM06990 | blood: | n/a |
5 | chr2:76337965-76338015 | PrEC | prostate: | n/a |
6 | chr2:76337965-76338015 | AG10803 | skin: | n/a |
7 | chr2:76337965-76338015 | HUVEC | blood vessel: | n/a |
8 | chr2:76337965-76338015 | HNPCEpiC | eye: | n/a |
9 | chr2:76337965-76338015 | BJ | skin: | n/a |
10 | chr2:76337965-76338015 | RPTEC | kidney: | n/a |
11 | chr2:76337965-76338015 | MCF10A-Er-Src | breast: | n/a |
12 | chr2:76337965-76338015 | AG09309 | skin: | n/a |
13 | chr2:76337965-76338015 | SK-N-MC | brain: | n/a |
14 | chr2:76337965-76338015 | PFSK-1 | brain: | n/a |
15 | chr2:76337965-76338015 | HCT-116 | colon: | n/a |
16 | chr2:76337965-76338015 | NHDF-neo | bronchial: | n/a |
17 | chr2:76337965-76338015 | ECC-1 | luminal epithelium: | n/a |
18 | chr2:76337965-76338015 | BE2_C | brain: | n/a |
19 | chr2:76337965-76338015 | ovcar-3 | ovarian: | n/a |
20 | chr2:76337965-76338015 | Jurkat | blood: | n/a |
21 | chr2:76337965-76338015 | NB4 | blood: | n/a |
22 | chr2:76337965-76338015 | HRPEpiC | eye: | n/a |
23 | chr2:76337965-76338015 | HL-60 | blood: | n/a |
24 | chr2:76337965-76338015 | MCF-7 | breast: | n/a |
25 | chr2:76337965-76338015 | ProgFib | skin: | n/a |
26 | chr2:76337965-76338015 | Hela-S3 | cervix: | n/a |
27 | chr2:76337965-76338015 | GM12892 | blood: | n/a |
28 | chr2:76337965-76338015 | HCPEpiC | choroid plexus: | n/a |
29 | chr2:76337965-76338015 | AG09319 | gingival: | n/a |
30 | chr2:76337965-76338015 | HEEpiC | esophagus: | n/a |
31 | chr2:76337965-76338015 | A549 | lung: | n/a |
32 | chr2:76337965-76338015 | T-47D | breast: | n/a |
33 | chr2:76337965-76338015 | GM19239 | blood: | n/a |
34 | chr2:76337965-76338015 | SK-N-SH | brain: | n/a |
35 | chr2:76337965-76338015 | HIPEpiC | eye: | n/a |
36 | chr2:76337965-76338015 | Caco-2 | colon: | n/a |
37 | chr2:76337965-76338015 | SK-N-SH_RA | brain: | n/a |
38 | chr2:76337965-76338015 | SAEC | small airway: | n/a |
39 | chr2:76337965-76338015 | AoSMC | blood vessel: | n/a |
40 | chr2:76337965-76338015 | AG04449 | skin: | fetal |
41 | chr2:76337965-76338015 | HCF | heart: | n/a |
42 | chr2:76337965-76338015 | HPAEpiC | pulmonary alveolar: | n/a |
43 | chr2:76337965-76338015 | HepG2 | liver: | n/a |
44 | chr2:76337965-76338015 | HRCEpiC | kidney: | n/a |
45 | chr2:76337965-76338015 | HAEpiC | amniotic membrane: | n/a |
46 | chr2:76337965-76338015 | Hepatocyte | liver: | n/a |
47 | chr2:76337965-76338015 | GM12891 | blood: | n/a |
48 | chr2:76337965-76338015 | AG04450 | lung: | fetal |
49 | chr2:76337965-76338015 | CMK | blood: | n/a |
50 | chr2:76337965-76338015 | HRE | kidney: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76291024..76293676-chr2:76337937..76340562,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SUCLA2P2 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187938854 | chr2:76337013-76337014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191607873 | chr2:76337044-76337045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564905923 | chr2:76337084-76337085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34372923 | chr2:76337106-76337107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547810569 | chr2:76337130-76337131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74908832 | chr2:76337131-76337132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572789855 | chr2:76337155-76337156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376491111 | chr2:76337157-76337158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540305611 | chr2:76337168-76337169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547559364 | chr2:76337200-76337201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145854729 | chr2:76337247-76337248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529007845 | chr2:76337251-76337252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17700553 | chr2:76337280-76337281 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs563884202 | chr2:76337305-76337306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531185187 | chr2:76337310-76337311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183336206 | chr2:76337337-76337338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553997545 | chr2:76337345-76337346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17012180 | chr2:76337346-76337347 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs528511320 | chr2:76337358-76337359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188795357 | chr2:76337392-76337393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568426867 | chr2:76337395-76337396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535561374 | chr2:76337452-76337453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192347889 | chr2:76337464-76337465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568755854 | chr2:76337536-76337537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539337724 | chr2:76337627-76337628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377037037 | chr2:76337652-76337653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10195421 | chr2:76337715-76337716 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs317290 | chr2:76337737-76337738 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs138486018 | chr2:76337749-76337750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376079052 | chr2:76337770-76337771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184769833 | chr2:76337791-76337792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115745358 | chr2:76337846-76337847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs317289 | chr2:76337861-76337862 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs186459632 | chr2:76337872-76337873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141330530 | chr2:76337873-76337874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34840105 | chr2:76337932-76337933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546505034 | chr2:76337940-76337941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6759090 | chr2:76337951-76337952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191309930 | chr2:76337965-76337966 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs546636715 | chr2:76337966-76337967 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs184651191 | chr2:76337973-76337974 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs529343303 | chr2:76337982-76337983 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs550699054 | chr2:76337984-76337985 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76332200-76337400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:76334400-76338600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr2:76334800-76337600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:76336200-76337600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr2:76336200-76338600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:76337400-76337800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:76337600-76337800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr2:76337600-76338000 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr2:76337600-76339200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr2:76337600-76339200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr2:76337600-76339200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr2:76337800-76338200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr2:76337800-76338600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr2:76338000-76338400 | Weak transcription | H1 Cell Line | embryonic stem cell |